TREASURE topline results show evidence of therapeutic impact Study preliminary results analyses indicate good potential for favorable results in Athersys’ MASTERS-2 study Conference call today at 8:30 a.m. ET CLEVELAND, Ohio–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX) announced today that its partner, HEALIOS K.K. (Healios), has reported topline results for its Japan […]
Neuro
Vesalio Announces Completion of Enrollment in it’s FDA Enabling Stroke Study
Nashville, TN (May 11, 2022) – Vesalio is excited to announce the completion of patient enrollment for the CLEAR1 FDA IDE study utilizing the NeVa™ thrombectomy platform. This is an important milestone for Vesalio to complete for entering the U.S. neurovascular market to treat patients suffering from acute ischemic stroke (AIS). AIS […]
Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)
– The eTrieve™ catheter for removing blood clots, based on electric fields, met safety and feasibility endpoints – Data, showing significant reduction RV/LV ratio and alleviation of PE associated symptoms, presented at Biomed Israel 2022 OR YEHUDA, Israel, May 10, 2022 /PRNewswire/ — Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the […]
MT2020+ Launches the #BEFASTchallenge to Raise Public Stroke Awareness
The viral social media effort will illustrate stroke symptom recognition, the timeliness to seek help and raise money WASHINGTON, May 10, 2022 /PRNewswire/ — Mission Thrombectomy 2020+ (MT2020+), a global initiative of the Society of Vascular and Interventional Neurology (SVIN), has created a worldwide dance challenge to raise awareness of stroke symptoms and the […]
Humacyte to Provide Human Acellular Vessels™ (HAVs™) to Front-line Hospitals in Ukraine for Treatment of Vascular Trauma Injuries
— First shipment of HAVs to six Ukrainian hospitals made today — — Product candidate to be used for civilian and military vascular trauma repair, the HAV’s lead investigational indication — DURHAM, N.C., May 09, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally […]
Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
– Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. – Paralysis is a devastating condition for more than 5 million patients in the United States NEW YORK & MELBOURNE, Australia–(BUSINESS WIRE)–Synchron, an endovascular brain-computer (BCI) interface company, today announced the enrollment of […]
STAR Network to Collaborate with Avail Surgical Telepresence Platform to Enhance Collaboration Among Physicians
With the Avail Platform, Collaborators participating in STAR — the Stroke Thrombectomy and Aneurysm Registry — Can Lean on each other and Work Together, Regardless of Location or Hour SANTA CLARA, Calif., May 3, 2022 /PRNewswire/ — Avail Medsystems, a healthcare technology company whose surgical telepresence platform facilitates real-time, interactive collaboration during live procedures among […]
Multi-center Clinical Study Data on Anaconda Biomed’s Mechanical Thrombectomy System Published in Stroke
ANA System Shown to Achieve High Rate of Complete Recanalization, Favorable 90 Day Outcomes BARCELONA, Spain–(BUSINESS WIRE)–Multi-center clinical study data supporting Anaconda Biomed’s ANA Advanced Neurovascular Access™ (ANA) Catheter System for treating ischemic stroke has been published in the journal Stroke. The SOLONDA (“SOL”itaire in combination with the ANA Catheter system manufactured […]
Biomodex® Announces Launch of Clear Cartridges for Neurovascular Training
Transparent 3D models allow MedTech companies to train physicians on new devices outside the cath lab BOSTON, March 31, 2022 /PRNewswire/ — Biomodex®, the leader in biorealistic haptic simulators for physician training and rehearsals, today announced the launch of Clear Cartridges for use with all Biomodex EVIAS™ and EVIAS Plus™ stations. The anatomically accurate clear cartridges […]
Cerus Endovascular Receives U.S. Food and Drug Administration 510(k) Clearance of its 027 Micro-catheter
– Company Announces Expansion of its Contour Neurovascular System™ Platform – FREMONT, Calif. and OXFORD, England, March 23, 2022 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 027 micro-catheters, available in two lengths, expanding […]



